Skip to main content
HR 896 108th Congress House

Breast Cancer Prescription Drug Fairness Act of 2003

Official title: To provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries and for women diagnosed with breast cancer.

Introduced: March 18, 2003 See on congress.gov
Health Breast cancerCommerceCongressCongressional reporting requirements
More subjectsShow fewer subjects
Drug industryDrugsGovernmental investigationsLife expectancyMedicarePharmaciesPrescription pricingPrice discriminationSocial WelfareTerminal careTerminally illWomenWomen's health
Sign in to write a letter Sign in to watch
This bill died when the 108th Congress ended
It never became law before the 108th Congress (2003–2004) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 10, 2003
Referred to the Subcommittee on Health.
Feb 25, 2003
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 25, 2003
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 10, 2003

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service
Breast Cancer Prescription Drug Fairness Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy a covered outpatient drug: (1) in an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries (including the amount sold or distributed to Medicare beneficiaries in a hospice program); and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
 Cosponsors 4
All 4 Democratic 2
D
Davis, Danny K.
Illinois · Mar 18, 2003
Bordallo, Madeleine
· Mar 13, 2003
 D
Doggett, Lloyd
Texas · Mar 4, 2003
FROST, MARTIN
· Mar 3, 2003
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 896: Breast Cancer Prescription Drug Fairness Act of 2003. 108th Congress. Open America. https://openamerica.io/bill/108-HR-896/
MLA
"H.R. 896: Breast Cancer Prescription Drug Fairness Act of 2003." 108th Congress, 2026, Open America, https://openamerica.io/bill/108-HR-896/.
Bluebook (legal)
H.R. 896, 108th Cong. (2026), https://openamerica.io/bill/108-HR-896/.
Markdown link
[H.R. 896: Breast Cancer Prescription Drug Fairness Act of 2003](https://openamerica.io/bill/108-HR-896/)
Report a problem